{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:41:31Z","timestamp":1791175291742,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.jaut.2007.12.002","type":"journal-article","created":{"date-parts":[[2008,2,5]],"date-time":"2008-02-05T08:33:50Z","timestamp":1202200430000},"page":"172-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation"],"prefix":"10.1016","volume":"30","author":[{"given":"Andrew R.","family":"Rezvani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer F.","family":"Storb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2007.12.002_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2141.1957.tb05793.x","article-title":"Treatment of murine leukaemia with x-rays and homologous bone marrow: II","volume":"3","author":"Barnes","year":"1957","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaut.2007.12.002_bib2","series-title":"Thomas' hematopoietic cell transplantation","first-page":"369","article-title":"Graft-vs.tumor responses","author":"Fefer","year":"2004"},{"key":"10.1016\/j.jaut.2007.12.002_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymthe.2005.09.011","article-title":"Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders (review)","volume":"13","author":"Baron","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaut.2007.12.002_bib4","first-page":"1130","article-title":"Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?","volume":"111","author":"Ringden","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaut.2007.12.002_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.immunol.25.022106.141606","article-title":"Immunobiology of allogeneic hematopoietic stem cell transplantation (review)","volume":"25","author":"Welniak","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaut.2007.12.002_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.critrevonc.2005.07.001","article-title":"Shared biology of GVHD and GVT effects: potential methods of separation (review)","volume":"57","author":"Fowler","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"10.1016\/j.jaut.2007.12.002_bib7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.jaut.2007.12.002_bib8","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1371\/journal.pmed.0040198","article-title":"Graft versus host disease \u2013 a surge of developments provide a new way forward","volume":"4","author":"Riddell","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.jaut.2007.12.002_bib9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.beha.2006.09.008","article-title":"Autoimmunity following haematopoietic stem-cell transplantation","volume":"20","author":"Daikeler","year":"2007","journal-title":"Bailliere's Best Pract Clin Haematol"},{"key":"10.1016\/j.jaut.2007.12.002_bib10","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1182\/blood.V100.10.3835","article-title":"Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL","volume":"100","author":"Bellantuono","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.12.002_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood-2003-07-2603","article-title":"Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic cell transplants","volume":"103","author":"Randolph","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.12.002_bib12","doi-asserted-by":"crossref","first-page":"8639","DOI":"10.1073\/pnas.96.15.8639","article-title":"CD8+ minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells","volume":"96","author":"Bonnet","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2007.12.002_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.beha.2006.09.002","article-title":"Risk assessment in haematopoietic stem cell transplantation: minor histocompatibility antigens (review)","volume":"20","author":"Hambach","year":"2007","journal-title":"Bailliere's Best Pract Clin Haematol"},{"key":"10.1016\/j.jaut.2007.12.002_bib14","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.4049\/jimmunol.149.5.1788","article-title":"Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens","volume":"149","author":"de Bueger","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2007.12.002_bib15","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1073\/pnas.0530192100","article-title":"Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia","volume":"100","author":"Marijt","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2007.12.002_bib16","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood.V93.7.2336","article-title":"Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens","volume":"93","author":"Mutis","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.12.002_bib17","first-page":"1415","article-title":"Adult and cord blood T cells can acquire HA-1 specificity through HA-1 T-cell receptor gene transfer","volume":"90","author":"Mommaas","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.jaut.2007.12.002_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bmt.1705057","article-title":"Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma","volume":"36","author":"Neelapu","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaut.2007.12.002_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbmt.2005.10.025","article-title":"Adoptive transfer of allogeneic antigen-specific T cells","volume":"12","author":"Riddell","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaut.2007.12.002_bib20","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood-2007-02-072843","article-title":"Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes","volume":"110","author":"Quintarelli","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.12.002_bib21","doi-asserted-by":"crossref","unstructured":"Ruggeri L, Mancusi A, Capanni M, Urbani E, Carotti A, Aloisi T, et al Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive valueBloodprepublished online March 19, 2007;doi:10.1182\/blood-2006-07-038687.","DOI":"10.1182\/blood-2006-07-038687"},{"key":"10.1016\/j.jaut.2007.12.002_bib22","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1182\/blood-2005-04-1644","article-title":"KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation","volume":"106","author":"Cooley","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.12.002_bib23","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1182\/blood-2006-10-048173","article-title":"The unexpected effect of cyclosporin A on CD56+ CD16\u2212 and CD56+ CD16+ natural killer cell subpopulations","volume":"110","author":"Wang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.12.002_bib24","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","article-title":"Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer","volume":"105","author":"Miller","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.12.002_bib25","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood-2006-05-024315","article-title":"Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donors","volume":"109","author":"Lundqvist","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.12.002_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.bmt.1704536","article-title":"CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot study","volume":"34","author":"Alyea","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaut.2007.12.002_bib27","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood-2005-08-3373","article-title":"A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3\/CD28 costimulation","volume":"107","author":"Porter","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.12.002_bib28","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1182\/blood-2005-08-3503","article-title":"Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation","volume":"107","author":"Berger","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.12.002_bib29","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1182\/blood-2004-11-4564","article-title":"An inducible caspase 9 safety switch for T-cell therapy","volume":"105","author":"Straathof","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.12.002_bib30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM198603203141201","article-title":"Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia","volume":"314","author":"Storb","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaut.2007.12.002_bib31","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood-2002-05-1340","volume":"101","author":"Niederwieser","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.12.002_bib32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.semcancer.2005.11.008","article-title":"CD4+ CD25+ regulatory T cells in human hematopoietic cell transplantation (review)","volume":"16","author":"Zorn","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jaut.2007.12.002_bib33","first-page":"566","article-title":"Expression of the putatively regulatory T-cell marker FOXP3 by CD4(+)CD25+ T cells after pediatric hematopoietic stem cell transplantation","volume":"91","author":"Seidel","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.jaut.2007.12.002_bib34","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.20060468","article-title":"Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells","volume":"203","author":"Seddiki","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2007.12.002_bib35","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1182\/blood-2004-11-4526","article-title":"Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity","volume":"106","author":"Sun","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.12.002_bib36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2005-05-1820","article-title":"NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145","volume":"107","author":"Vodanovic-Jankovic","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.12.002_bib37","doi-asserted-by":"crossref","first-page":"944","DOI":"10.4049\/jimmunol.177.2.944","article-title":"Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells","volume":"177","author":"Valmori","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2007.12.002_bib38","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.0400380101","article-title":"Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect","volume":"101","author":"Reddy","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2007.12.002_bib39","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2007.12.002_bib40","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease","volume":"81","author":"Ringd\u00e9n","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.jaut.2007.12.002_bib41","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.bmt.1705644","article-title":"IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation","volume":"39","author":"Min","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaut.2007.12.002_bib42","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaut.2007.12.005","article-title":"Bone marrow stem cell transplant into intra-bone cavity prevent Type 2 diabetes: role of heme oxygenase-adiponectin","volume":"30","author":"Abraham","year":"2008","journal-title":"J Autoimmun"},{"issue":"1\u20132","key":"10.1016\/j.jaut.2007.12.002_bib43","first-page":"90","article-title":"The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases","volume":"30","author":"Boren","year":"2007","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2007.12.002_bib44","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaut.2007.12.010","article-title":"Hematopoietic stem cell\u00a0transplantation for autoimmune diseases: what have we learned?","volume":"30","author":"Burt","year":"2008","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2007.12.002_bib45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaut.2007.12.001","article-title":"On reversing the persistence of memory: hematopoietic stem cell transplant for autoimmune disease in the first ten years","volume":"30","author":"Deane","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2007.12.002_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaut.2007.12.006","article-title":"Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara","volume":"30","author":"Gershwin","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2007.12.002_bib47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jaut.2007.12.007","article-title":"In vivo bioimaging using photogenic rats: fate of injected bone marrow-derived mesenchymal stromal cells","volume":"30","author":"Hara","year":"2008","journal-title":"J\u00a0Autoimmun"},{"issue":"1\u20133","key":"10.1016\/j.jaut.2007.12.002_bib48","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12026-007-0004-4","article-title":"Innovative BMT method for intractable diseases","volume":"38","author":"Ikehara","year":"2007","journal-title":"Immunol Res"},{"key":"10.1016\/j.jaut.2007.12.002_bib49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaut.2007.12.009","article-title":"Will hematopoietic stem cell transplantation cure human autoimmune diseases?","volume":"30","author":"Marmont","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2007.12.002_bib50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jaut.2007.12.008","article-title":"Cell and gene therapy using mesenchymal stem cells (MSCs)","volume":"30","author":"Ozawa","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2007.12.002_bib51","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jaut.2007.12.003","article-title":"Hunt for pluripotent stem cell \u2013 regenerative medicine search for almighty cell","volume":"30","author":"Ratajczak","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2007.12.002_bib52","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaut.2007.12.004","article-title":"Immunophenotype and functional characteristics of human primitive CD34-negative hematopoietic stem cells: the significance of the intra-bone marrow injection","volume":"30","author":"Sonoda","year":"2008","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.jaut.2007.12.002_bib53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0268-960X(03)00007-9","article-title":"The graft-versus-leukemia response after allogeneic hematopoietic stem cell transplantation","volume":"17","author":"Riddell","year":"2003","journal-title":"Blood Rev"},{"issue":"15","key":"10.1016\/j.jaut.2007.12.002_bib54","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1056\/NEJMp078166","article-title":"Hematopoietic cell transplantation at 50","volume":"357","author":"Appelbaum","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jaut.2007.12.002_bib55","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2003-02-0342","article-title":"Graft-versus-leukemia reactions in allogeneic chimeras","volume":"103","author":"Kolb","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jaut.2007.12.002_bib56","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","article-title":"Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation","volume":"15","author":"Collins","year":"1997","journal-title":"J Clin Oncol"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841107001436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841107001436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T07:59:08Z","timestamp":1760255948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841107001436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0896841107001436"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2007.12.002","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2007.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}